00:38 , Mar 23, 2017 |  BC Innovations  |  Distillery Therapeutics

Cancer

INDICATION: Multiple myeloma (MM) Patient sample, cell culture and mouse studies suggest bispecific antibodies targeting CD3 and either BCMA or FCRL5 could help treat multiple myeloma (MM). In MM cells from patients and human MM...